2024 annual financial data

Candel Therapeutics 2024 Operating margin

Direct answer

Operating margin was Not calculable.

Operating income was -33.37M USD and net income was -55.18M USD.
Operating cash flow was Not available.

Get free Candel Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-33.37M USD
Net income
-55.18M USD
Operating cash flow
Not available